A research team has discovered the structure of a novel RNA-modifying enzyme, ZCCHC4, and identified the mechanism that controls how this enzyme recognizes its substrate. ZCCHC4 influences cell proliferation and has been linked to cancers. The discovery has applications in structure-based drug design against cancers.